144 results
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
, unincorporated organization, investment fund, any other business entity and a governmental entity or any department, agency or political subdivision
8-K
EX-4.2
ho1qalz2tt ywjc4
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-4.1
nzyd5 sbeko
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-10.1
8vnmz33yzgfde4bhhv4
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
8-K
EX-99.1
hk6ixshfj tk
5 Mar 24
Regulation FD Disclosure
8:51am
8-K
gne6uwugma9v5ax5
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
8-K
EX-10.2
rc19000
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.3
fxok5gba
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
dff777y
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
318k2blx9chat bte
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.3
ndb sp3ga1p94
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
pbimm
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
n4p9frtvlxczwt
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-4.3
psjxc8q3byw08 f0f8j1
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm